Budgetary Provision of ₹13,000 cr for Bio-Pharma SHAKTI and 3 dedicated Chemical Parks in the country is a strategic bet on India’s future said Union Minister of Chemicals and Fertilisers Shri J P Nadda. Addressing the post-Budget Webinar on the theme “Sustaining and Strengthening Economic Growth”  today he said that as emphasised by Prime Minister Shri Narendra Modi in his opening remarks FTAs are a gateway for ...

An Industry Interaction on the theme “Scaling up Pharma Exports” was held under the Chintan Shivir series being taken forward under the guidance of Prime Minister Shri Narendra Modi. The interaction reflected the Government’s priority of expanding India’s export footprint through closer coordination with industry and regulators. India’s pharmaceutical export performance continues to show steady growth. Pharmaceutical exports stood at ...

India’s pharmaceutical exports stood at USD 30.47 billion in 2024–25, registering a growth of 9.4 percent over the previous year, supported by a strong manufacturing base and expanding global outreach, said Commerce Secretary Shri Rajesh Agrawal while inaugurating a one-day Regional Chintan Shivir on Pharmaceutical Exports. The Commerce Secretary also highlighted that India’s domestic pharmaceutical market is currently estimated at ...

To increase access to medicines in rural areas, the Pharmaceuticals & Medical Devices Bureau of India, the implementing agency of PMBJP has partnered with the Cooperative sector to open Jan Aushadhi Kendras through Primary Agriculture Cooperative Societies (PACS). Till 30th November 2024, more than 2690 PACS have been given initial approval and 687 Kendras have been opened in PACS. The ...

The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers is announce the Revamped Pharmaceuticals Technology Upgradation Assistance (RPTUAS) Scheme. It is a significant step in government’s efforts to help upgrade the technological capabilities of our pharmaceutical industry and ensure its alignment with the global standards. The approval of the revised Scheme follows a comprehensive review by the Scheme Steering Committee ...

MSMEs have availed the benefit under erstwhile PTUAS scheme. However, the PTUAS has been incorporated as a sub-scheme under the Scheme – Strengthening of Pharmaceutical Industry (SPI), which was launched in July 2022. The Strengthening of Pharmaceutical Industry (SPI), with the financial outlay of Rs. 500 crores and with a tenure from FY 2021-2022 to FY 2025-26, has following three components, ...

The Department implements the scheme “Promotion of Medical Devices Parks”, with a total financial outlay of Rs. 400 crore and the maximum assistance under the scheme for one Medical Device Park would be limited to Rs. 100 crore. The tenure of the scheme is from FY 2020-2021 to FY 2024-2025 and the selected Medical Device Park project will be implemented ...

The Government has put in place a Uniform Code for Pharmaceutical Marketing Practices (UCPMP) for Pharmaceutical companies, which is in operation since 01.01.2015, to prevent unethical practices by the pharmaceutical companies. This code governs the conduct of pharmaceutical companies in their marketing practices, duly covering the various aspects such as medical representatives, textual and audio-visual promotional materials, samples, gifts, etc. ...

The Government of India has established Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H), as a subordinate office under Ministry of Ayush by merging Pharmacopoeia Commission of Indian Medicine & Homoeopathy (PCIM&H) and the two central laboratories namely Pharmacopoeia Laboratory for Indian Medicine (PLIM), Ghaziabad and Homoeopathic Pharmacopoeia Laboratory (HPL) vide gazette dated 6th July, 2020). The Commission is engaged ...

The Competition Commission of India (CCI) has released here today a report titled ‘Market Study on the Pharmaceutical Sector in India: Key Findings and Observations’ (‘the study’). The report may be accessed at: http://cci.gov.in/sites/default/files/whats_newdocument/Market-Study-on-the–Pharmaceutical–Sector-in-India.pdf With the overarching objective of understanding the factors that influence price competition in the pharmaceutical sector, the study focused on the specific realms of pharmaceutical distribution and the ...